293 related articles for article (PubMed ID: 30854032)
1. The glycosylation landscape of pancreatic cancer.
Munkley J
Oncol Lett; 2019 Mar; 17(3):2569-2575. PubMed ID: 30854032
[TBL] [Abstract][Full Text] [Related]
2. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLe
Guerrero PE; Duran A; Ortiz MR; Castro E; Garcia-Velasco A; Llop E; Peracaula R
J Proteomics; 2021 Jan; 231():104004. PubMed ID: 33038510
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor cell sialylation in pancreatic cancer progression.
Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
[TBL] [Abstract][Full Text] [Related]
5. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation Changes in Prostate Cancer Progression.
Butler W; Huang J
Front Oncol; 2021; 11():809170. PubMed ID: 35004332
[TBL] [Abstract][Full Text] [Related]
7. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
8. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
10. Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
Radhakrishnan P; Dabelsteen S; Madsen FB; Francavilla C; Kopp KL; Steentoft C; Vakhrushev SY; Olsen JV; Hansen L; Bennett EP; Woetmann A; Yin G; Chen L; Song H; Bak M; Hlady RA; Peters SL; Opavsky R; Thode C; Qvortrup K; Schjoldager KT; Clausen H; Hollingsworth MA; Wandall HH
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):E4066-75. PubMed ID: 25118277
[TBL] [Abstract][Full Text] [Related]
11. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
12. Glycans as Biomarkers in Prostate Cancer.
Scott E; Munkley J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893936
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.
Singh S; Pal K; Yadav J; Tang H; Partyka K; Kletter D; Hsueh P; Ensink E; Kc B; Hostetter G; Xu HE; Bern M; Smith DF; Mehta AS; Brand R; Melcher K; Haab BB
J Proteome Res; 2015 Jun; 14(6):2594-605. PubMed ID: 25938165
[TBL] [Abstract][Full Text] [Related]
14. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
[TBL] [Abstract][Full Text] [Related]
15. The Role of Sialyl-Tn in Cancer.
Munkley J
Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
[TBL] [Abstract][Full Text] [Related]
16. Glycoforms of human endothelial CD34 that bind L-selectin carry sulfated sialyl Lewis x capped O- and N-glycans.
Hernandez Mir G; Helin J; Skarp KP; Cummings RD; Mäkitie A; Renkonen R; Leppänen A
Blood; 2009 Jul; 114(3):733-41. PubMed ID: 19359410
[TBL] [Abstract][Full Text] [Related]
17. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
18. Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
Mereiter S; Magalhães A; Adamczyk B; Jin C; Almeida A; Drici L; Ibáñez-Vea M; Gomes C; Ferreira JA; Afonso LP; Santos LL; Larsen MR; Kolarich D; Karlsson NG; Reis CA
Biochim Biophys Acta; 2016 Aug; 1860(8):1795-808. PubMed ID: 26721331
[TBL] [Abstract][Full Text] [Related]
19. Precise structural analysis of O-linked oligosaccharides in human serum.
Yabu M; Korekane H; Miyamoto Y
Glycobiology; 2014 Jun; 24(6):542-53. PubMed ID: 24663386
[TBL] [Abstract][Full Text] [Related]
20. Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity.
Mitoma J; Petryniak B; Hiraoka N; Yeh JC; Lowe JB; Fukuda M
J Biol Chem; 2003 Mar; 278(11):9953-61. PubMed ID: 12529363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
